These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30461452)

  • 1. Scaling up pre-exposure prophylaxis in sub-Saharan Africa.
    Ahmed N; Pike C; Bekker LG
    Curr Opin Infect Dis; 2019 Feb; 32(1):24-30. PubMed ID: 30461452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
    Price JT; Wheeler SB; Stranix-Chibanda L; Hosek SG; Watts DH; Siberry GK; Spiegel HM; Stringer JS; Chi BH
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S145-53. PubMed ID: 27355502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART?
    O'Malley G; Barnabee G; Mugwanya K
    Curr HIV/AIDS Rep; 2019 Apr; 16(2):141-150. PubMed ID: 30796608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaling up preexposure prophylaxis to maximize HIV prevention impact.
    Grulich AE; Bavinton BR
    Curr Opin HIV AIDS; 2022 Jul; 17(4):173-178. PubMed ID: 35762370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy.
    Cáceres CF; Borquez A; Klausner JD; Baggaley R; Beyrer C
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21108. PubMed ID: 27760685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
    Bhavaraju N; Shears K; Schwartz K; Mullick S; Jeckonia P; Murungu J; Persaud U; Vij A; Torjesen K
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):508-517. PubMed ID: 34910276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study.
    Masyuko S; Mukui I; Njathi O; Kimani M; Oluoch P; Wamicwe J; Mutegi J; Njogo S; Anyona M; Muchiri P; Maikweki L; Musyoki H; Bahati P; Kyongo J; Marwa T; Irungu E; Kiragu M; Kioko U; Ogando J; Were D; Bartilol K; Sirengo M; Mugo N; Baeten JM; Cherutich P; PrEP Technical Working Group OBOT
    Sex Health; 2018 Nov; 15(6):578-586. PubMed ID: 30408432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaching at-risk women for PrEP delivery: What can we learn from clinical trials in sub-Saharan Africa?
    Stankevitz K; Schwartz K; Hoke T; Li Y; Lanham M; Mahaka I; Mullick S
    PLoS One; 2019; 14(6):e0218556. PubMed ID: 31226165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
    PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward.
    Case KK; Gomez GB; Hallett TB
    J Int AIDS Soc; 2019 Sep; 22(9):e25390. PubMed ID: 31538407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing the use of Long-Acting Extended Delivery formulations for HIV prevention in sub-Saharan Africa: challenges, opportunities, and recommendations.
    Mgodi NM; Murewanhema G; Moyo E; Samba C; Musuka G; Dzinamarira T; Brown JM
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26115. PubMed ID: 37439069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrEP Communications Accelerator: a digital demand creation tool for sub-Saharan Africa.
    Schwartz K; Ferrigno B; Vining S; Gomez A; Briedenhann E; Gardiner E; Jeckonia P; Torjesen K
    Sex Health; 2018 Nov; 15(6):570-577. PubMed ID: 30408430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM; Mansoor LE; Abdool Karim Q
    AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
    Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
    BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposure prophylaxis (PrEP) in an era of stalled HIV prevention: Can it change the game?
    Eakle R; Venter F; Rees H
    Retrovirology; 2018 Apr; 15(1):29. PubMed ID: 29609619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
    Krakower DS; Mayer KH
    Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-exposure Prophylaxis Adherence Measured by Plasma Drug Level in MTN-001: Comparison Between Vaginal Gel and Oral Tablets in Two Geographic Regions.
    Minnis AM; van der Straten A; Salee P; Hendrix CW
    AIDS Behav; 2016 Jul; 20(7):1541-8. PubMed ID: 25969178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.